⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 4, 2026Journal of Case Reports and Images in OncologyOpen Access

Complete remission of metastatic mismatch repairdeficient/microsatellite instability-high esophageal adenocarcinoma following immunotherapy: A case report

Eric Ka Chai LEE Suat Loo Aparna Juneja

View Full Paper

Ask AI

Bookmark

Share

Key Points

To describe the effects of immunotherapy on a patient with metastatic mismatch repair deficient esophageal adenocarcinoma.
Immunotherapy treatment was administered to a patient with metastatic disease.
Patient's response to treatment was monitored over time for signs of remission.
Patient achieved complete remission of metastatic cancer following immunotherapy.
No recurrence of disease has been reported at follow-up.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Case report shows complete remission of advanced cancer using immunotherapy, suggesting new treatment potential.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

LEE et al. (2026) studied this question.

synapsesocial.com/papers/6a743773764cddc9499d4c98 https://doi.org/10.5348/100158z10el2026ci

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A Rare Case of Complete Remission in Metastatic Esophageal Squamous Cell Carcinoma: Potential Abscopal Effect of Combined Immunotherapy and Radiotherapy: A Case ReportCase Report · 2026
2Case report: A case study of neoadjuvant immunochemotherapy for locally advanced esophageal squamous carcinoma2024 · 1 citations
3Use of Chemoimmunotherapy for Locally Advanced Deficient Mismatch Repair (dMMR) Gastric Adenocarcinoma With Curative Intent: A Case Report2024 · 1 citations
4CRE24-033: Complete Remission of Microsatellite Instability–High (MSI-H) Oligometastatic Poorly Differentiated Colon Adenocarcinoma After a Single Dose of Immunotherapy2024
5Chemo-immunotherapy sequential with radiotherapy and immunotherapy consolidation in patients with advanced or metastatic esophageal squamous cell carcinoma.Clinical Trial · 2026

Endoscopic histological validation of clinical complete response after neoadjuvant chemoimmunotherapy for esophageal cancer2026
Case Report: Synchronous Esophageal Squamous Cell Carcinoma and Gastric Cardia Adenocarcinoma with Hepatoid Differentiation After Neoadjuvant Chemoimmunotherapy2026
Therapeutic management of resectable mismatch-repair deficient/microsatellite instability-high gastroesophageal adenocarcinoma: a real-world analysis from Austria2026
Soft tissue sarcoma unmasked: An atypical presentation of primary cutaneous B-cell lymphomaJournal of Case Reports and Images in Oncology · 2026
From mechanism to mitigation: Addressing ponatinib’s cerebral arterial occlusion riskJournal of Case Reports and Images in Oncology · 2026

More from Journal of Case Reports and Images in Oncology

More from Colchester Hospital